1. Home
  2. VANI vs EEA Comparison

VANI vs EEA Comparison

Compare VANI & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • EEA
  • Stock Information
  • Founded
  • VANI 1998
  • EEA 1986
  • Country
  • VANI United States
  • EEA Germany
  • Employees
  • VANI N/A
  • EEA N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EEA Trusts Except Educational Religious and Charitable
  • Sector
  • VANI Health Care
  • EEA Finance
  • Exchange
  • VANI Nasdaq
  • EEA Nasdaq
  • Market Cap
  • VANI 73.5M
  • EEA 67.9M
  • IPO Year
  • VANI 2014
  • EEA N/A
  • Fundamental
  • Price
  • VANI $1.18
  • EEA $10.49
  • Analyst Decision
  • VANI Strong Buy
  • EEA
  • Analyst Count
  • VANI 1
  • EEA 0
  • Target Price
  • VANI $4.00
  • EEA N/A
  • AVG Volume (30 Days)
  • VANI 134.0K
  • EEA 9.2K
  • Earning Date
  • VANI 08-13-2025
  • EEA 01-01-0001
  • Dividend Yield
  • VANI N/A
  • EEA 1.92%
  • EPS Growth
  • VANI N/A
  • EEA N/A
  • EPS
  • VANI N/A
  • EEA N/A
  • Revenue
  • VANI N/A
  • EEA N/A
  • Revenue This Year
  • VANI N/A
  • EEA N/A
  • Revenue Next Year
  • VANI N/A
  • EEA N/A
  • P/E Ratio
  • VANI N/A
  • EEA N/A
  • Revenue Growth
  • VANI N/A
  • EEA N/A
  • 52 Week Low
  • VANI $0.91
  • EEA $7.45
  • 52 Week High
  • VANI $1.80
  • EEA $9.26
  • Technical
  • Relative Strength Index (RSI)
  • VANI 33.74
  • EEA 49.70
  • Support Level
  • VANI $1.18
  • EEA $10.47
  • Resistance Level
  • VANI $1.26
  • EEA $10.79
  • Average True Range (ATR)
  • VANI 0.05
  • EEA 0.18
  • MACD
  • VANI -0.01
  • EEA -0.02
  • Stochastic Oscillator
  • VANI 0.00
  • EEA 17.07

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

Share on Social Networks: